Xiu-jie Sheng

P.R. China
Guangzhou, 510150, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR‑543 axis.

Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR‑543 axis.

Journal: Oncology letters

Published: July 17, 2024

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

Journal: NPJ precision oncology

Published: January 16, 2024

Mechanism of hsa_circ_0069443 promoting early pregnancy loss through ALKBH5/FN1 axis in trophoblast cells.

Mechanism of hsa_circ_0069443 promoting early pregnancy loss through ALKBH5/FN1 axis in trophoblast cells.

Journal: iScience

Published: December 26, 2023

SNORD99 promotes endometrial cancer development by inhibiting GSDMD-mediated pyroptosis through 2'-O-methylation modification.

SNORD99 promotes endometrial cancer development by inhibiting GSDMD-mediated pyroptosis through 2'-O-methylation modification.

Journal: Journal of cellular and molecular medicine

Published: October 20, 2023

circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.

circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 26, 2018

CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.

CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 15, 2018

TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer.

TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer.

Journal: Theranostics

Published: September 26, 2018

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET.

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET.

Journal: Oncology letters

Published: October 23, 2013

Application of video endoscopic inguinal lymphadenectomy in radical vulvectomy for carcinoma

Application of video endoscopic inguinal lymphadenectomy in radical vulvectomy for carcinoma

Journal: Zhonghua yi xue za zhi

Published: October 16, 2013

Surgical technique of video endoscopic inguinal lymphadenectomy via a hypogastric subcutaneous approach.

Surgical technique of video endoscopic inguinal lymphadenectomy via a hypogastric subcutaneous approach.

Journal: Chinese medical journal

Published: August 29, 2013

The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy

The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy

Journal: Zhonghua fu chan ke za zhi

Published: January 11, 2013

Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.

Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.

Journal: Journal of Zhejiang University. Science. B

Published: November 06, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026